ABCL
AbCellera Biologics Inc. · Healthcare
Chief Financial Officer Andrew Booth bought $384K of AbCellera Biologics Inc.
Bought$383,904
$10.32Price
37,200Shares
+8%Stake
What ABCL did for a copier
- $1,000 copied at Fri, Aug 14 close, $11.38
- $1,302
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Sep 29 close.
Andrew Booth's record
3 other buys with 3 months of prices since 2021: on average +28.2% against the S&P 500, and 2 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 14. Filed Fri, Aug 14, 12:04 PM ET, during the session. Returns use the Aug 14 close and the Sep 29 close. Not investment advice.